Angola vs Niger: Cause of death, by non-communicable diseases, ages 5-14, female
Angola
18.7%
in 2021
Niger
18.9%
in 2021
Angola rank
162nd
Niger rank
161st
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Angola
- Niger
How they compare
Niger currently reports 18.9% against 18.7% in Angola, a difference of 0.2%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Niger ahead.
Angola ranks 162nd and Niger ranks 161st of 184 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Angola | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.3% | 13.9% | 2.6% | Niger |
| 2010s | 17.4% | 17.1% | 0.4% | Angola |
| 2020s | 18.6% | 18.7% | 0.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Angola or Niger?
- Niger, at 18.9% against 18.7% in Angola as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Angola and Niger?
- 0.2%, with Niger ahead.
- How many years of comparable data are there for Angola and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Niger rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Angola ranks 162nd and Niger ranks 161st of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.